Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision

NCT00627302 is registered in ClinicalTrials.gov with Bp Consulting, Inc as lead sponsor.

NCT NCT00627302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00627302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision
Lead sponsor
Bp Consulting, Inc
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2008
Completion date
November 30, 2008
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopia